Edesa Biotech is trading 6.46% up at $3.79 on September 30, 2026; no specific catalyst has been identified. - Shares closed at $3.56 on September 29; a premarket quote was $3.95, up 10.96%. - No new company announcement explaining the move was found; the latest listed releases are the August 19 public-offering announcements. - Broader markets were mixed: the Nasdaq rose 0.98% and the S&P 500 rose 0.47%.